BRCA1 and neoplasm: To define differential PARP1 interacting proteins, we harnessed these olaparib and rucaparib analogs for chemical proteomics experiments with the BRCA1-isogenic UWB cell line pair and with OC patient tumor tissues that were collected prior to drug therapy (Fig. 2A and Table S1).